Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.15 USD
Change Today +0.02 / 1.77%
Volume 68.1K
ATHX On Other Exchanges
Symbol
Exchange
NASDAQ CM
As of 3:42 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

athersys inc (ATHX) Key Developments

Athersys, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter Ended June 30, 2015

Athersys, Inc. reported unaudited consolidated earnings results for the second quarter ended June 30, 2015. For the quarter, the company reported total revenues of $216,000 compared to $388,000 a year ago, reflecting a decrease in grant revenues. Loss from operations was of $7,034,000 compared to $7,286,000, a year ago. Net loss and comprehensive loss was $1,035,000 or $0.05 per diluted share compared to net income and comprehensive net income of $675,000 or $0.04 per diluted share a year ago. Cash used in operating activities during the second quarter of 2015 was $5.8 million compared to $6.1 million cash used in the second quarter of 2014. The increase in net loss reflects the $200,000 reduction in loss from operations is offset by the $1.9 million increase in noncash expense from warrant liability valuation.

Athersys, Inc. to Report Q2, 2015 Results on Aug 06, 2015

Athersys, Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Aug 06, 2015

Athersys, Inc., Q2 2015 Earnings Call, Aug 06, 2015

Athersys, Inc., Q2 2015 Earnings Call, Aug 06, 2015

Athersys, Inc. Reports Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015

Athersys, Inc. reported unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, total revenues were $731,000 compared to $707,000 a year ago. Loss from operations was $6,893,000, compared to $7,389,000 a year ago. Net loss and comprehensive loss was $12,482,000 compared to $11,484,000 a year ago. The increase in net loss reflects a $496,000 reduction in loss from operations as offset by the impact of the $1.5 million increase in expense from the change in fair value of warrant liabilities. Basic and diluted net loss per common share was $0.16 against $0.15 a year ago. The net loss includes a non-cash expense of $5.6 million related to the change in fair value of warrant liabilities and $0.8 million related to stock-based compensation, working out to $0.08 a share. Excluding the items, the company would have reported a loss of $0.08. Cash provided by operating activities was $1.1 million compared to cash used by operating activities of $7.3 million in the first quarter of 2014.

Athersys, Inc., Annual General Meeting, Jun 24, 2015

Athersys, Inc., Annual General Meeting, Jun 24, 2015., at 08:00 US Eastern Standard Time. Location: Marriott Hotel at Key Center. Agenda: To consider the election of seven Directors nominated by the Board of Directors; to consider and ratify the appointment of Ernst & Young LLP as Athersys, Inc.’s independent auditors for the fiscal year ending December 31, 2015; and approve, on an advisory basis, named executive officer compensation.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ATHX:US $1.15 USD +0.02

ATHX Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Biorestorative Therapies Inc $7.42 USD -0.83
Caladrius Biosciences Inc $1.64 USD -0.06
Cytori Therapeutics Inc $0.35 USD -0.0279
Pluristem Therapeutics Inc $1.91 USD +0.01
StemCells Inc $0.48 USD +0.0201
View Industry Companies
 

Industry Analysis

ATHX

Industry Average

Valuation ATHX Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 63.5x
Price/Book 4.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales 41.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ATHERSYS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.